Deterministic sensitivity analysis of cohort and treatment factors.

*Population weighted average (white male 44%, white female 45%, black male 5%, black female 6%). Each strategy is compared to the next-best strategy on the efficient frontier. Risk factors were considered for all of these scenario analyses but are dominated in all cases. **Prevalence based on 1962–1971 cohort. &Adherence is defined as patients taking ≥80% of their HCV medications. “Dominated” indicates that the strategy costs more and provides fewer benefits than another strategy or a combination of two strategies.